IMPDH Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of IMPDH monoclonal antibodies for investigating inosine monophosphate dehydrogenase (IMPDH) in cellular processes. IMPDH monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IMPDH functions as a key enzyme in the de novo synthesis pathway of purine nucleotides, playing a crucial role in cell proliferation and immune response. The regulation of IMPDH is vital for maintaining nucleotide balance and has been implicated in various diseases, including cancer and autoimmune disorders. Understanding IMPDH activity and its inhibitors presents significant therapeutic potential for developing new treatment strategies. Researchers can utilize IMPDH monoclonal antibodies to explore cellular pathways, disease mechanisms, and potential therapeutic targets. IMPDH monoclonal antibodies enable precise detection and quantification in diverse experimental settings. The reliability and specificity of Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic approaches.